How to cite item

Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies

   
@article{TLCR13143,
	author = {Charles B. Simone II and Abigail T. Berman and Salma K. Jabbour},
	title = {Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies},
	journal = {Translational Lung Cancer Research},
	volume = {6},
	number = {2},
	year = {2017},
	keywords = {},
	abstract = {Thoracic malignancies are among the most lethal group of tumors. The most common thoracic malignancy, lung cancer, is histologically grouped as non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Nearly three-fifths of NSCLC patients and two-thirds of SCLC patients present with stage IV disease, and the median survival of both of these groups approximates one year (1,2). Malignant pleural mesothelioma is a malignancy of the mesothelial lining of the pleura and is associated with a median survival of 12–18 months (3,4). While thymic malignancies often present at an early stage, only approximately half of patients with stage III-IV thymoma will achieve a 5-year survival, and that percentage falls to approximately 30% for patients with stage III-IV thymic carcinoma (5,6).},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/13143}
}